Dangerous Drugs - Cymbalta

In October 2005, Eli Lilly, the creators of the anti-depression drug Cymbalta, expanded its warning regarding the drug. The cautionary label of the drug now informs consumers of potential liver-related problems and advises healthcare professionals to refrain from prescribing the drug to patients with liver problems or chronic liver disease. U.S. health regulators also included warnings regarding hepatitis, jaundice and other liver-related diseases which have been linked to Cymbalta.

In addition, the FDA has issued an advisory regarding the potential for suicidal thinking in adults taking antidepressants, specifically the higher-than-expected rate of suicide attempts by users of Cymbalta. The studies which supplemented these findings were reflecting the higher incidence of suicidal thoughts found during clinical trials of the drug. 

A common explanation for higher suicide rates in anti-depressant users is their existing depression, but a more recent study has yielded telling results. Of 9,000 female Cymbalta users surveyed, 11 of those women tried to commit suicide. What is notable about this study is that the women had all been prescribed the drug as part of their treatment for urinary incontinence, a condition that does not induce depression. 

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else's fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.